These positive results are tempered by a recent report from Parihar et al., which showed the emergence of new brain metastasis with 68Ga-PSMA uptake, after 177Lu-PSMA and 225Ac-PSMA treatment of prostate cancer [65]. This evidence concerns the gene FOLH1 and prostate carcinoma.